Ying, X., Grau-Spulveda, M., Schwamm, L. H., Bhatt, D. L., Smith, E. E., Reeves, M. J., … Peterson, E. D. (n.d.). Risk of intracranial hemorrhage among acute ischemic stroke patients receiving prior antiplatelet therapy and treated with intravenous tissue plasminogen activator. Presented at the American Heart Association Quality of Care and Outcomes Research Scientific Sessions.

Ying, X., M. Grau-Spulveda, L. H. Schwamm, D. L. Bhatt, E. E. Smith, M. J. Reeves, Jeff Federspiel, et al. “Risk of intracranial hemorrhage among acute ischemic stroke patients receiving prior antiplatelet therapy and treated with intravenous tissue plasminogen activator.,” n.d.

Ying X, Grau-Spulveda M, Schwamm LH, Bhatt DL, Smith EE, Reeves MJ, et al. Risk of intracranial hemorrhage among acute ischemic stroke patients receiving prior antiplatelet therapy and treated with intravenous tissue plasminogen activator. In.

Ying, X., et al. Risk of intracranial hemorrhage among acute ischemic stroke patients receiving prior antiplatelet therapy and treated with intravenous tissue plasminogen activator.

Ying X, Grau-Spulveda M, Schwamm LH, Bhatt DL, Smith EE, Reeves MJ, Federspiel J, Thomas L, Prvu-Bettger J, Laskowitz DT, Hernandez AF, Fonarow GC, Peterson ED. Risk of intracranial hemorrhage among acute ischemic stroke patients receiving prior antiplatelet therapy and treated with intravenous tissue plasminogen activator.